Conference SAN DIEGO, July 3, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune..., Receptos (858) 652-5708 gcooper@receptos.com Source: Receptos, Inc. News Provided by Acquire Media Close window | Back to top delicious Digg Facebook LinkedIn Twitter Yahoo! Buzz Copyright 2013 Receptos, Inc ...Next Release Share this on: Delicious Digg Facebook LinkedIn Twitter What is this? Previous Release | Next Release July 3, 2013 Receptos to Present at JMP Securities Healthcare...

DIEGO, July 22, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic... and Investor Contact: Graham K. Cooper Chief Financial Officer, Receptos (858) 652-5708 gcooper@receptos.com Source: Receptos, Inc. News Provided by Acquire Media Close window... | Back to top delicious Digg Facebook LinkedIn Twitter Yahoo! Buzz Copyright 2013 Receptos, Inc ...

Receptos Inc. - Terms of Use home team executive teamboard of directorsscientific advisory boardRMS clinical advisory boardIBD clinical advisory board clinical pipeline S1P1R... are incorporated herein by reference. If you do not agree to these terms, do not use this Site. General This website (this "Site") is owned and operated by Receptos Inc. ("Receptos.... terms of use privacy home team clinical pipeline research & technology corporate partnering contact 2013 Receptos, Inc. All Rights Reserved. ...

on June 28, 2013 SAN DIEGO, June 26, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune...: Graham K. Cooper Chief Financial Officer, Receptos (858) 652-5708 gcooper@receptos.com Source: Receptos, Inc. News Provided by Acquire Media Close window | Back to top delicious Digg Facebook LinkedIn Twitter Yahoo! Buzz Copyright 2013 Receptos, Inc ...Next Release Share this on: Delicious Digg Facebook LinkedIn Twitter What is this? Previous Release | Next Release June 26, 2013 Receptos to be Added to Russell 3000(R) Index...

Receptos Inc. home team executive teamboard of directorsscientific advisory boardRMS clinical advisory boardIBD clinical advisory board clinical pipeline S1P1R modulator..., 2013Receptos Provides Update on Progress of Lead Product Candidate RPC1063 MORE terms of use privacy home team clinical pipeline research & technology corporate partnering contact 2013 Receptos, Inc. All Rights Reserved. ... receptos publications corporate governance financial information stock information contact IR contactcareersdirections about receptos We are a biopharmaceutical company focused...